Clinical review: Consensus recommendations on measurement of blood glucose and reporting glycemic control in critically ill adults
Simon Finfer(The George Institute for Global Health), Tom Van Herpe(KU Leuven), Marcus J. Schultz(University of St.Gallen), Thomas Desaive(University of Liège), Jean‐Charles Preiser(Université Libre de Bruxelles), Jeffrey I. Joseph(Thomas Jefferson University), James S. Krinsley(Stamford Hospital), Mikhail Kosiborod(AstraZeneca (Brazil)), Robbert J. Slingerland(Isala), Jan Wernerman(Karolinska University Hospital), Greet Van den Berghe(KU Leuven), Tony Cass, Mitchell G. Scott(Washington University in St. Louis), Dieter Mesotten(KU Leuven), Iain Mackenzie(The Edgbaston Hospital), Roman Hovorka(Wellcome/MRC Institute of Metabolic Science)
Cited by 207
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
ESPEN guidelines on nutrition in cancer patients
|Clinical Nutrition|2016|3k
ESPEN guideline on clinical nutrition in the intensive care unit
|Clinical Nutrition|2018|2.8k
International Consensus on Use of Continuous Glucose Monitoring
|Diabetes Care|2017|2k